450 results on '"Ugolini, Clara"'
Search Results
2. Does thyroglossal duct arborization play a role in the post-surgical outcome of Sistrunk procedure in children?
3. Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action
4. Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion
5. Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs’ development
6. Hashimoto Thyroiditis
7. Chronic Thyroiditis
8. Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study
9. The BRAF K601E mutation in thyroid tumors: One alteration with a dual clinical significance
10. Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classic Papillary Thyroid Cancer
11. Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations
12. Goiter
13. De Quervain Thyroiditis
14. Basedow Disease
15. Thyroglossal Duct Cyst
16. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
17. Sarcina Ventriculi infection: a rare but fearsome event. A Systematic Review of the Literature
18. Thyroid Hyperplasia
19. Thyroid Agenesis
20. Thyroid Cysts
21. Pathology of Thyroid Cancer
22. Role of Prophylactic Central Compartment Lymph Node Dissection on the Outcome Of Patients With Papillary Thyroid Carcinoma and Synchronous Ipsilateral Cervical Lymph Node Metastases
23. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
24. Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing
25. Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology.
26. Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology
27. Delphi expert consensus for whole slide imaging in thyroid cytopathology
28. Hashimoto Thyroiditis
29. Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas
30. Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer
31. Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome
32. NF1 gene inactivation acts as a tumor driver in RET/RAS-negative medullary thyroid carcinomas
33. HER2-low in gastro-oesophageal adenocarcinoma: a real-world pathological perspective
34. Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosis
35. Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience
36. Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study
37. Minor role of TP53and TERTpromoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature
38. miRNA expression profiling of ‘noninvasive follicular thyroid neoplasms with papillary-like nuclear features' compared with adenomas and infiltrative follicular variants of papillary thyroid carcinomas
39. Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E -Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy.
40. Diagnosi per immagini istologiche, immunoistochimiche e sonografiche di un raro caso di plasmocitoma scarsamente differenziato della tiroide
41. Fenotipo misto MEN2A/MEN2B da nuova mutazione germinale di RET: prima descrizione clinico-genetica e iconografia
42. Supplementary Figure 1 from A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
43. Supplementary Table 4 from A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
44. Supplementary Table 5 from A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
45. Supplementary Table 2 from A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
46. Supplementary Table 1 from A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
47. Supplementary Table 3 from A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
48. Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy
49. Autopsy Study of Testicles in COVID-19: Upregulation of Immune-Related Genes and Downregulation of Testis-Specific Genes
50. Tumor-to-Tumor Metastasis: Lung Typical Carcinoid Metastatic to Follicular Variant of Papillary Thyroid Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.